Boston Scientific, Medtronic and St. Jude in high-stakes heart-valve race

[Star Tribune, March 15, 2015] An 85-year-old Minneapolis woman lies on the operating room table at Abbott Northwestern ­Hospital and waits for the future of heart valve medicine.

The diseased aortic valve in Anna Schu’s chest is threatening her health, but she’s not a good candidate for open-heart surgery. So she’s decided to have an experimental procedure and become the first person in ­Minnesota to get a new device from Boston Scientific Corp. that is implanted through an incision in her leg to make it easier on her body.

Read the entire story at startribune.com.